Osteoarthritis affects the majority of senior dogs and is frequently undertreated, making pain recognition and multimodal management critical for maintaining quality of life.
Canine osteoarthritis is massively underdiagnosed because dogs mask pain as a survival instinct, and owners often attribute reduced activity to normal aging. Validated pain scoring tools like the Helsinki Chronic Pain Index help owners and vets detect subtle signs. Multimodal pain management combining anti-inflammatory medication, weight control, and physical therapy provides the best welfare outcomes. Novel monoclonal antibody treatments targeting nerve growth factor offer new hope for refractory cases.